Company

BCAL Diagnostics Ltd

Headquarters: Sydney, NSW, Australia

ASX: BDX +4.76%

Detailed Description

BCAL Diagnostics Limited, a biotechnology company, engages in developing a non-invasive laboratory blood test for the detection of breast cancer. It develops BCAL test, a lipid biomarker blood test with the potential to be used for breast cancer prevention, screening, and monitoring; and in vitro diagnostic test (IVD) that confirms a fingerprint of lipid biomarkers extracted from extracellular vesicles from a patient's plasma or blood sample to diagnose the presence of breast cancer cells in a patient's body. The company was incorporated in 2010 and is headquartered in Sydney, Australia.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

BCAL Diagnostics Ltd has the following listings and related stock indices.


Stock: ASX: BDX wb_incandescent

Details

Headquarters:

50 Clarence Street

Suite 506 Level 5

Sydney, NSW 2000

Australia

Phone: 61 2 9078 7671